Zai Lab Ltd
ZLAB32.650USD
-0.350-1.06%
Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min
3.59BCap. mercado
PérdidaP/E TTM
Más Datos de Zai Lab Ltd Compañía
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Información de la empresa
Símbolo de cotizaciónZLAB
Nombre de la empresaZai Lab Ltd
Fecha de salida a bolsaSep 28, 2020
Director ejecutivoDr. Ying (Samantha) Du, Ph.D.
Número de empleados1869
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 28
DirecciónBuilding B, 899 Halei Road, Pudong
CiudadSHANGHAI
Bolsa de valoresNASDAQ Global Market Consolidated
PaísChina
Código postal201203
Teléfono862161632588
Sitio Webhttps://www.zailaboratory.com/
Símbolo de cotizaciónZLAB
Fecha de salida a bolsaSep 28, 2020
Director ejecutivoDr. Ying (Samantha) Du, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Dr. Richard B. Gaynor, M.D.
Dr. Richard B. Gaynor, M.D.
Independent Director
Independent Director
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Ms. Christine Chiou
Ms. Christine Chiou
Senior Vice President, Head - Investor Relations
Senior Vice President, Head - Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Otro
3.03M
2.86%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Otro
3.03M
2.86%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Otro
79.72%
Accionistas
Accionistas
Proporción
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Otro
79.72%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
16.87%
Investment Advisor
16.18%
Hedge Fund
5.50%
Individual Investor
1.74%
Private Equity
1.38%
Venture Capital
1.13%
Research Firm
0.89%
Pension Fund
0.44%
Sovereign Wealth Fund
0.18%
Otro
55.69%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
2023Q4
497
46.31M
46.92%
-16.57M
2023Q3
537
44.27M
45.68%
-20.42M
2023Q2
568
47.21M
48.74%
-23.76M
2023Q1
572
60.29M
61.61%
-11.82M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Capital World Investors
6.01M
5.41%
-425.00K
-6.61%
Mar 31, 2025
RTW Investments L.P.
3.14M
2.82%
+627.56K
+25.01%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.68M
4.21%
+945.91K
+25.33%
Mar 31, 2025
ClearBridge Investments, LLC
3.28M
2.95%
+1.42M
+76.05%
Mar 31, 2025
Janus Henderson Investors
3.81M
3.43%
-2.75M
-41.94%
Mar 31, 2025
Baron Capital Management, Inc.
1.83M
1.65%
-79.59K
-4.17%
Mar 31, 2025
Segantii Capital Management Limited
1.56M
1.4%
-131.64K
-7.80%
Mar 31, 2024
Wellington Management Company, LLP
3.65M
3.28%
-3.01M
-45.22%
Mar 31, 2025
Fidelity Institutional Asset Management
1.70M
1.53%
-43.29K
-2.49%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
SPDR Portfolio MSCI Global Stock Market ETF
0%
Innovator IBD 50 Fund ETF
0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
National Security Emerging Markets Index ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
0%
DFA Dimensional Emerging Core Equity Market ETF
0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
0%
WisdomTree Emerging Markets Efficient Core Fund
0%
SPDR Portfolio MSCI Global Stock Market ETF
Proporción0%
Innovator IBD 50 Fund ETF
Proporción0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
Proporción0%
ProShares Ultra Nasdaq Biotechnology
Proporción0%
National Security Emerging Markets Index ETF
Proporción0%
Invesco Nasdaq Biotechnology ETF
Proporción0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
Proporción0%
DFA Dimensional Emerging Core Equity Market ETF
Proporción0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
Proporción0%
WisdomTree Emerging Markets Efficient Core Fund
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
